Susan P Etheridge

Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (3)

Year:

2024

BACKGROUND: Whether vigorous exercise increases risk of ventricular arrhythmias for individuals diagnosed and treated for congenital long QT syndrome (LQTS) remains unknown. METHODS: The National Institutes of Health–funded LIVE-LQTS study (Lifestyle and Exercise in the Long QT Syndrome) prospectively enrolled individuals 8 to 60 years of age with phenotypic and/or genotypic LQTS from 37 sites in 5 countries from May 2015 to February 2019. Participants (or parents) answered physical activity and clinical events surveys every 6 months for 3 years with follow-up completed in February 2022. Vigorous exercise was defined as ≥6 metabolic equivalents for >60 hours per year. A blinded Clinical Events Committee adjudicated the composite end point of sudden death, sudden cardiac arrest, ventricular arrhythmia treated by an implantable cardioverter defibrillator, and likely arrhythmic syncope. A National Death Index search ascertained vital status for those with incomplete follow-up. A noninferiority hypothesis (boundary of 1.5) between vigorous exercisers and others was tested with multivariable Cox regression analysis. RESULTS: Among the 1413 participants (13% <18 years of age, 35% 18–25 years of age, 67% female, 25% with implantable cardioverter defibrillators, 90% genotype positive, 49% with LQT1, 91% were treated with beta-blockers, left cardiac sympathetic denervation, and/or implantable cardioverter defibrillator), 52% participated in vigorous exercise (55% of these competitively). Thirty-seven individuals experienced the composite end point (including one sudden cardiac arrest and one sudden death in the nonvigorous group, one sudden cardiac arrest in the vigorous group) with overall event rates at 3 years of 2.6% in the vigorous and 2.7% in the nonvigorous exercise groups. The unadjusted hazard ratio for experience of events for the vigorous group compared with the nonvigorous group was 0.97 (90% CI, 0.57–1.67), with an adjusted hazard ratio of 1.17 (90% CI, 0.67–2.04). The upper 95% one-sided confidence level extended beyond the 1.5 boundary. Neither vigorous or nonvigorous exercise was found to be superior in any group or subgroup. CONCLUSIONS: Among individuals diagnosed with phenotypic and/or genotypic LQTS who were risk assessed and treated in experienced centers, LQTS-associated cardiac event rates were low and similar between those exercising vigorously and those not exercising vigorously. Consistent with the low event rate, CIs are wide, and noninferiority was not demonstrated. These data further inform shared decision-making discussions between patient and physician about exercise and competitive sports participation. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02549664.

Year:

2024

Background The utility of genetic testing in cardiovascular medicine is well-established in expert consensus statements for optimizing patient care. However, significant genetic testing care gaps persist for patients with inherited cardiovascular conditions. Objective This study aimed to understand why genetic testing care gaps in cardiovascular medicine exist by evaluating cardiovascular providers’ opinions and use of genetic testing. Methods We developed and administered an anonymous survey to cardiovascular providers delivering direct patient care in the United States. Participants were contacted in collaboration with the Sudden Arrhythmia Death Syndromes (SADS) Foundation. Results A total of 111 individuals completed the survey representing the following specialties: electrophysiology (55%, n=61), general cardiology (10.8%, n=12), imaging (7.2%, n=8), heart failure/transplant (6.3%, n=7), interventional cardiology (6.3%, n=7), fetal cardiology (5.4%, n=6), and other (9%, n=10). Eighty-six percent of respondents (n=97) stated genetic testing is ‘very relevant’ in the care of their patients. Eighty percent of electrophysiologists reported ordering genetic testing a few times a month or more. Navigating insurance authorization and billing procedures was an identified area of discomfort by 47.7% of respondents (n=53). Overall, cardiovascular provider specialty was shown to impact how often genetic testing is ordered. Provider work setting was shown to impact opinion of the utility of genetic testing for family screening, opinion of the utility of genetic testing for medication and device management, and how often genetic testing is ordered. Conclusions The results of this study support targeted provider education to increase the uptake of genetic testing for patients with inherited cardiovascular conditions.

Year:

2024

Collaborators (18)

Sharlene Day

Associate Professor

University of Pennsylvania

UNITED STATES
View details

Bryan Cannon

Professor of Pediatrics

Texas Children's Hospital

UNITED STATES
View details

Silvana Molossi

Associate Professor, Associate Chief of Cardiology

Baylor College of Medicine

UNITED STATES
View details

Gregory Webster

Northwestern University Feinberg School of Medicine

UNITED STATES
View details

Belinda Gray

University of Sydney

AUSTRALIA
View details

Elijah R Behr

Director

University College London

UNITED KINGDOM
View details

Maria Teresa Tome Esteban

Consultant cardiologist and Professor of Practice_ cardiology

St George’s, University of London

UNITED KINGDOM
View details

James Ware

Professor

Imperial College London

UNITED KINGDOM
View details

Marina Cerrone

Research Assistant Professor of Medicine

NYU School of Medicine

UNITED STATES
View details

Martin Tristani

Professor

University of Utah

UNITED STATES
View details

Brian Olshansky

Electrophysiologist

-

UNITED STATES
View details

Cynthia James

Associate Professor

Johns Hopkins University

UNITED STATES
View details

Wojciech Zareba

Professor of Medicine/Cardiology

University of Rochester Medical Center

UNITED STATES
View details

Kimberly Harmon

Professor

University of Washington

UNITED STATES
View details

Prince Kannankeril

Professor

Vanderbilt University Medical Center

UNITED STATES
View details

Shubhayan Sanatani

Professor

The University of British Columbia

CANADA
View details

Rachel Lampert

Yale University School of Medicine

UNITED STATES
View details

Ilan Goldenberg

-

UNITED STATES
View details